On the one hand, CXCL9/CXCR3 promotes anti‐tumor immunity by attracting CXCR3+ cytotoxic lymphocytes to the tumor microenvironment, which can inhibit tumor growth [51]. The gene discussed is CXCL9; the disease is neoplasm.